| 
																	
																	
																		 Matthew Clary
 
																		 Concepts  (208)
																		
																	 
																		Concepts are derived automatically from a person's publications. 
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
 | Laryngostenosis | 7 | 2025 | 51 | 1.270 | Why? |  | Vocal Cords | 3 | 2017 | 32 | 1.020 | Why? |  | Injections | 3 | 2017 | 182 | 0.750 | Why? |  | Laryngoscopy | 6 | 2021 | 105 | 0.680 | Why? |  | Laryngeal Diseases | 4 | 2018 | 31 | 0.680 | Why? |  | Otolaryngology | 3 | 2023 | 96 | 0.660 | Why? |  | Cough | 2 | 2020 | 121 | 0.560 | Why? |  | Endoscopy | 4 | 2013 | 315 | 0.550 | Why? |  | Laryngitis | 1 | 2017 | 4 | 0.540 | Why? |  | Cricoid Cartilage | 2 | 2020 | 17 | 0.540 | Why? |  | Vocal Cord Paralysis | 3 | 2024 | 29 | 0.520 | Why? |  | Deglutition Disorders | 3 | 2019 | 143 | 0.490 | Why? |  | Tracheotomy | 3 | 2024 | 23 | 0.480 | Why? |  | Laryngoplasty | 1 | 2014 | 6 | 0.450 | Why? |  | Ambulatory Surgical Procedures | 1 | 2013 | 65 | 0.390 | Why? |  | Esophagoscopy | 2 | 2024 | 206 | 0.380 | Why? |  | Airway Obstruction | 3 | 2020 | 162 | 0.360 | Why? |  | Arachnoid Cysts | 1 | 2011 | 7 | 0.360 | Why? |  | Dilatation | 1 | 2011 | 65 | 0.360 | Why? |  | Ear Diseases | 1 | 2011 | 15 | 0.360 | Why? |  | Ear, Middle | 1 | 2011 | 92 | 0.350 | Why? |  | Bacteria | 1 | 2017 | 855 | 0.330 | Why? |  | Anti-Bacterial Agents | 2 | 2018 | 1790 | 0.330 | Why? |  | Equipment Design | 4 | 2015 | 523 | 0.290 | Why? |  | Voice Training | 2 | 2018 | 6 | 0.270 | Why? |  | Dysphonia | 2 | 2018 | 15 | 0.270 | Why? |  | Larynx | 3 | 2020 | 60 | 0.270 | Why? |  | Office Visits | 2 | 2017 | 91 | 0.240 | Why? |  | Middle Aged | 17 | 2024 | 33118 | 0.240 | Why? |  | Retrospective Studies | 15 | 2024 | 15514 | 0.230 | Why? |  | Laryngopharyngeal Reflux | 2 | 2021 | 15 | 0.220 | Why? |  | Obesity, Morbid | 2 | 2024 | 257 | 0.200 | Why? |  | Voice Quality | 2 | 2015 | 18 | 0.200 | Why? |  | Glottis | 3 | 2017 | 20 | 0.200 | Why? |  | Chemoreceptor Cells | 3 | 2020 | 54 | 0.200 | Why? |  | Female | 26 | 2024 | 72703 | 0.200 | Why? |  | Esophagus | 1 | 2024 | 255 | 0.190 | Why? |  | Esophagitis, Peptic | 1 | 2021 | 15 | 0.180 | Why? |  | Humans | 37 | 2025 | 136899 | 0.180 | Why? |  | Tracheostomy | 1 | 2023 | 132 | 0.180 | Why? |  | Aged | 10 | 2024 | 23641 | 0.180 | Why? |  | Postoperative Complications | 3 | 2024 | 2627 | 0.180 | Why? |  | Adult | 16 | 2024 | 37595 | 0.170 | Why? |  | Male | 22 | 2024 | 67308 | 0.170 | Why? |  | Sleep Apnea, Obstructive | 1 | 2024 | 290 | 0.170 | Why? |  | Respiration Disorders | 1 | 2020 | 77 | 0.170 | Why? |  | Clinical Trials as Topic | 1 | 2025 | 1037 | 0.160 | Why? |  | Arytenoid Cartilage | 1 | 2019 | 7 | 0.160 | Why? |  | Research Design | 1 | 2025 | 1108 | 0.150 | Why? |  | Dyspnea | 3 | 2016 | 251 | 0.150 | Why? |  | Aged, 80 and over | 5 | 2018 | 7552 | 0.140 | Why? |  | Microsurgery | 1 | 2018 | 79 | 0.140 | Why? |  | Methylcellulose | 1 | 2017 | 2 | 0.140 | Why? |  | Spirometry | 1 | 2019 | 276 | 0.140 | Why? |  | Vocal Cord Dysfunction | 2 | 2015 | 10 | 0.140 | Why? |  | Antibiotic Prophylaxis | 1 | 2018 | 117 | 0.140 | Why? |  | Body Mass Index | 2 | 2024 | 2351 | 0.140 | Why? |  | Social Determinants of Health | 1 | 2021 | 246 | 0.140 | Why? |  | Taste Buds | 2 | 2019 | 212 | 0.130 | Why? |  | Perioperative Care | 1 | 2018 | 182 | 0.130 | Why? |  | Follow-Up Studies | 5 | 2021 | 5126 | 0.120 | Why? |  | Laser Therapy | 2 | 2019 | 134 | 0.120 | Why? |  | Drug Resistance, Bacterial | 1 | 2017 | 180 | 0.120 | Why? |  | Microbial Sensitivity Tests | 1 | 2017 | 362 | 0.120 | Why? |  | Hyaluronic Acid | 1 | 2017 | 223 | 0.120 | Why? |  | Surgical Wound Infection | 1 | 2018 | 301 | 0.120 | Why? |  | Speech-Language Pathology | 1 | 2015 | 21 | 0.120 | Why? |  | Exercise Test | 2 | 2016 | 621 | 0.110 | Why? |  | Preoperative Care | 1 | 2017 | 356 | 0.110 | Why? |  | Young Adult | 7 | 2018 | 13157 | 0.110 | Why? |  | Exercise | 2 | 2016 | 2015 | 0.110 | Why? |  | Obesity | 2 | 2024 | 2966 | 0.110 | Why? |  | Needles | 1 | 2014 | 59 | 0.110 | Why? |  | Simulation Training | 1 | 2015 | 98 | 0.110 | Why? |  | Heart Rate | 2 | 2017 | 830 | 0.100 | Why? |  | Respiratory Sounds | 1 | 2014 | 123 | 0.100 | Why? |  | Treatment Outcome | 6 | 2023 | 10768 | 0.100 | Why? |  | Branchial Region | 1 | 2013 | 37 | 0.100 | Why? |  | Optical Devices | 1 | 2013 | 13 | 0.100 | Why? |  | Fiber Optic Technology | 1 | 2013 | 23 | 0.100 | Why? |  | Biopsy | 1 | 2017 | 1130 | 0.100 | Why? |  | History, 19th Century | 1 | 2013 | 61 | 0.100 | Why? |  | Laryngoscopes | 1 | 2013 | 38 | 0.100 | Why? |  | Peak Expiratory Flow Rate | 2 | 2024 | 37 | 0.100 | Why? |  | Health Care Costs | 1 | 2015 | 386 | 0.090 | Why? |  | Choanal Atresia | 1 | 2011 | 2 | 0.090 | Why? |  | Equipment Safety | 1 | 2011 | 38 | 0.090 | Why? |  | History, 20th Century | 1 | 2013 | 324 | 0.090 | Why? |  | Tomography, X-Ray Computed | 4 | 2024 | 2670 | 0.090 | Why? |  | Surgical Flaps | 2 | 2010 | 148 | 0.090 | Why? |  | Cholesteatoma, Middle Ear | 1 | 2011 | 3 | 0.090 | Why? |  | Prospective Studies | 5 | 2023 | 7543 | 0.090 | Why? |  | Chronic Disease | 1 | 2017 | 1773 | 0.090 | Why? |  | Neuroma | 1 | 2011 | 7 | 0.090 | Why? |  | Facial Neoplasms | 1 | 2011 | 20 | 0.090 | Why? |  | Confidence Intervals | 1 | 2011 | 328 | 0.090 | Why? |  | Masks | 1 | 2011 | 62 | 0.090 | Why? |  | Miller Fisher Syndrome | 1 | 2010 | 2 | 0.090 | Why? |  | Blood Pressure | 2 | 2017 | 1774 | 0.090 | Why? |  | Ear, External | 1 | 2010 | 24 | 0.080 | Why? |  | Speech Disorders | 1 | 2010 | 34 | 0.080 | Why? |  | Voice Disorders | 1 | 2010 | 22 | 0.080 | Why? |  | Surgery, Computer-Assisted | 1 | 2011 | 99 | 0.080 | Why? |  | Infant, Premature, Diseases | 1 | 2011 | 101 | 0.080 | Why? |  | Feasibility Studies | 1 | 2014 | 943 | 0.080 | Why? |  | Otitis Media | 1 | 2012 | 165 | 0.080 | Why? |  | Diagnosis, Differential | 2 | 2011 | 1484 | 0.080 | Why? |  | Kaplan-Meier Estimate | 1 | 2011 | 892 | 0.080 | Why? |  | Surgical Wound Dehiscence | 1 | 2009 | 25 | 0.080 | Why? |  | Negative-Pressure Wound Therapy | 1 | 2009 | 24 | 0.080 | Why? |  | Odds Ratio | 1 | 2011 | 1063 | 0.080 | Why? |  | Periosteum | 1 | 2008 | 13 | 0.070 | Why? |  | Orbital Cellulitis | 1 | 2008 | 17 | 0.070 | Why? |  | Multivariate Analysis | 1 | 2011 | 1524 | 0.070 | Why? |  | Abscess | 1 | 2008 | 76 | 0.070 | Why? |  | Mouth Neoplasms | 1 | 2009 | 120 | 0.070 | Why? |  | Patient Satisfaction | 1 | 2011 | 657 | 0.070 | Why? |  | Risk Assessment | 2 | 2017 | 3432 | 0.060 | Why? |  | Logistic Models | 1 | 2011 | 2060 | 0.060 | Why? |  | Cohort Studies | 2 | 2018 | 5711 | 0.060 | Why? |  | Inflammation | 1 | 2017 | 2817 | 0.060 | Why? |  | United States | 3 | 2021 | 14595 | 0.060 | Why? |  | North America | 1 | 2025 | 312 | 0.050 | Why? |  | Adolescent | 5 | 2018 | 21402 | 0.050 | Why? |  | Fishes | 1 | 2024 | 100 | 0.050 | Why? |  | Otolaryngologists | 1 | 2023 | 13 | 0.050 | Why? |  | Polysomnography | 1 | 2024 | 184 | 0.050 | Why? |  | Severity of Illness Index | 1 | 2011 | 2833 | 0.050 | Why? |  | Carcinoma, Squamous Cell | 1 | 2009 | 683 | 0.050 | Why? |  | Foreign Bodies | 1 | 2024 | 104 | 0.050 | Why? |  | Immunohistochemistry | 2 | 2019 | 1739 | 0.050 | Why? |  | Recurrence | 2 | 2021 | 1058 | 0.050 | Why? |  | Sensitivity and Specificity | 2 | 2019 | 1945 | 0.050 | Why? |  | Reoperation | 2 | 2020 | 568 | 0.050 | Why? |  | Oxygen Consumption | 2 | 2016 | 681 | 0.050 | Why? |  | Constriction, Pathologic | 1 | 2023 | 242 | 0.050 | Why? |  | Device Removal | 1 | 2023 | 138 | 0.050 | Why? |  | Time Factors | 2 | 2024 | 6802 | 0.050 | Why? |  | Intubation, Intratracheal | 1 | 2024 | 259 | 0.050 | Why? |  | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.050 | Why? |  | Consensus | 1 | 2025 | 678 | 0.050 | Why? |  | Proton Pumps | 1 | 2021 | 8 | 0.050 | Why? |  | Pepsin A | 1 | 2021 | 19 | 0.050 | Why? |  | Laryngeal Nerves | 1 | 2020 | 7 | 0.040 | Why? |  | Apnea | 1 | 2020 | 22 | 0.040 | Why? |  | Reflex | 1 | 2020 | 69 | 0.040 | Why? |  | Proton Pump Inhibitors | 1 | 2021 | 108 | 0.040 | Why? |  | Lasers, Gas | 1 | 2019 | 5 | 0.040 | Why? |  | Prognosis | 2 | 2019 | 4011 | 0.040 | Why? |  | Brain Stem | 1 | 2020 | 104 | 0.040 | Why? |  | Surveys and Questionnaires | 2 | 2024 | 5730 | 0.040 | Why? |  | Laryngeal Mucosa | 1 | 2019 | 8 | 0.040 | Why? |  | Pilot Projects | 1 | 2024 | 1684 | 0.040 | Why? |  | Anticoagulants | 1 | 2023 | 662 | 0.040 | Why? |  | Nerve Fibers | 1 | 2019 | 96 | 0.040 | Why? |  | Cadaver | 1 | 2019 | 318 | 0.040 | Why? |  | Prevalence | 1 | 2024 | 2709 | 0.040 | Why? |  | Symptom Assessment | 1 | 2018 | 126 | 0.030 | Why? |  | Risk Factors | 2 | 2024 | 10313 | 0.030 | Why? |  | Tachycardia | 1 | 2017 | 58 | 0.030 | Why? |  | Patient Reported Outcome Measures | 1 | 2019 | 398 | 0.030 | Why? |  | Synaptosomal-Associated Protein 25 | 1 | 2015 | 26 | 0.030 | Why? |  | Phospholipase C beta | 1 | 2015 | 30 | 0.030 | Why? |  | Transducin | 1 | 2015 | 42 | 0.030 | Why? |  | Clinical Protocols | 1 | 2017 | 268 | 0.030 | Why? |  | Video Recording | 1 | 2016 | 184 | 0.030 | Why? |  | Ubiquitin Thiolesterase | 1 | 2015 | 43 | 0.030 | Why? |  | Child | 4 | 2018 | 21896 | 0.030 | Why? |  | Asthma, Exercise-Induced | 1 | 2014 | 8 | 0.030 | Why? |  | Epithelium | 1 | 2015 | 315 | 0.030 | Why? |  | Microscopy, Fluorescence | 1 | 2015 | 402 | 0.030 | Why? |  | Cross-Sectional Studies | 1 | 2024 | 5398 | 0.030 | Why? |  | Observer Variation | 1 | 2014 | 343 | 0.030 | Why? |  | Otorhinolaryngologic Surgical Procedures | 1 | 2013 | 40 | 0.030 | Why? |  | Patient Selection | 1 | 2017 | 690 | 0.030 | Why? |  | Hemodynamics | 1 | 2017 | 1114 | 0.020 | Why? |  | Incidence | 1 | 2018 | 2783 | 0.020 | Why? |  | Disease Progression | 1 | 2019 | 2744 | 0.020 | Why? |  | Sympathetic Nervous System | 1 | 1992 | 181 | 0.020 | Why? |  | Education, Medical, Graduate | 1 | 2015 | 476 | 0.020 | Why? |  | Infant, Low Birth Weight | 1 | 2011 | 139 | 0.020 | Why? |  | Velopharyngeal Insufficiency | 1 | 2010 | 11 | 0.020 | Why? |  | Physical Endurance | 1 | 1992 | 274 | 0.020 | Why? |  | Palate, Soft | 1 | 2010 | 14 | 0.020 | Why? |  | Hypesthesia | 1 | 2010 | 17 | 0.020 | Why? |  | Paresthesia | 1 | 2010 | 16 | 0.020 | Why? |  | Japan | 1 | 2010 | 116 | 0.020 | Why? |  | Isometric Contraction | 1 | 1992 | 188 | 0.020 | Why? |  | Neurologic Examination | 1 | 2010 | 113 | 0.020 | Why? |  | Referral and Consultation | 1 | 2015 | 779 | 0.020 | Why? |  | Granulation Tissue | 1 | 2009 | 6 | 0.020 | Why? |  | Travel | 1 | 2010 | 130 | 0.020 | Why? |  | Radiography | 1 | 2011 | 834 | 0.020 | Why? |  | Fibula | 1 | 2009 | 50 | 0.020 | Why? |  | Diabetes Complications | 1 | 2010 | 226 | 0.020 | Why? |  | Hypertension | 1 | 2017 | 1291 | 0.020 | Why? |  | Quality of Life | 1 | 2020 | 2847 | 0.020 | Why? |  | Animals | 2 | 2020 | 36915 | 0.020 | Why? |  | Infant, Premature | 1 | 2011 | 563 | 0.020 | Why? |  | Internship and Residency | 1 | 2015 | 1131 | 0.010 | Why? |  | Cardiovascular Diseases | 1 | 2017 | 2110 | 0.010 | Why? |  | Smoking | 1 | 2010 | 1633 | 0.010 | Why? |  | Mice | 1 | 2019 | 17775 | 0.010 | Why? |  | Infant, Newborn | 1 | 2011 | 6043 | 0.010 | Why? |  | Infant | 1 | 2008 | 9408 | 0.010 | Why? |  | Child, Preschool | 1 | 2008 | 11013 | 0.010 | Why? |  | Forearm | 1 | 1992 | 120 | 0.010 | Why? |  | Physical Exertion | 1 | 1992 | 212 | 0.010 | Why? | 
 | 
																	
																		
																			
																					
    Clary's Networks
 
Click the "See All" links for more information and interactive visualizations!
 Concepts  Derived automatically from this person's publications._ Co-Authors  People in Profiles who have published with this person._ Similar People  People who share similar concepts with this person._ 
            
                Same Department   
				People who are also in this person's primary department.
			 Physical Neighbors  People whose addresses are nearby this person._ |